Lion Street Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Lion Street Advisors, LLC
- $306 Million
- Q1 2025
A detailed history of Lion Street Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 333,725 shares of CRDL stock, worth $467,214. This represents 0.11% of its overall portfolio holdings.
Number of Shares
333,725
Previous 307,666
8.47%
Holding current value
$467,214
Previous $396,000
18.43%
% of portfolio
0.11%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding CRDL
# of Institutions
43Shares Held
7.82MCall Options Held
25.9KPut Options Held
1.7K-
Tejara Capital LTD London, X03.19MShares$4.47 Million1.2% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD982KShares$1.38 Million0.19% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9783KShares$1.1 Million0.35% of portfolio
-
Ubs Group Ag498KShares$696,9990.0% of portfolio
-
Pvg Asset Management Corp Golden, CO437KShares$612,3061.99% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $86.7M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...